• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ELI LILLY AND COMPANY HUMAPEN ERGO II; FOR TREATMENT PURPOSES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ELI LILLY AND COMPANY HUMAPEN ERGO II; FOR TREATMENT PURPOSES Back to Search Results
Model Number MS9557
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Hyperglycemia (1905)
Event Date 01/31/2019
Event Type  Injury  
Manufacturer Narrative
Narrative field; new updated and corrected information is referenced within the update statements in describe event or problem.Please refer to statement dated (b)(6) 2021 in the describe event or problem field.No further follow up is planned.Evaluation summary: the reporter stated the patient was using the same application pen for almost 6-7 years.There was no product complaint for the device, and the device was not returned for investigation.There was evidence of improper use of the device.The same application pen was used for almost 6-7 years.The user manual states do not use your pen for more than 3 years after the first use or past the use-by date on the carton.
 
Event Description
(b)(4).This solicited case, reported by a consumer via a patient support program (psp), concerned a (b)(6) female patient of unknown origin.Medical history included diabetes mellitus, blood pressure in bad condition, kidney disorder and was on dialysis since 1986.Concomitant medication included insulin glargine for the treatment of diabetes mellitus and unspecified medication for heart disorder, kidney and high blood pressure.The patient received human insulin (rdna origin) injection (humulin r) from cartridge via a humapen ergo ii re-usable device 22 units daily (8 in morning, 8 in noon and 6 in evening) via unknown route, for the treatment of diabetes mellitus, beginning somewhere in 2014.She was using the same humapen ergo ii device since six to seven years which was considered to be improper use.On an unknown date in 2019, she experienced loss of consciousnesses, heart disorder, all levels were high of blood sugar and blood pressure.On (b)(6) "20219", she got hospitalized for 15 days in emergency due to these events.On (b)(6) 2021, her husband died and her event of loss of consciousness got worse and she also experienced depression since then.She was also on dialysis.Some where in (b)(6) 2021, she lost her humapen ergo ii device.Information regarding the corrective treatment, outcome of the events and the status of the human insulin therapy was not provided.The operator of the humapen ergo ii re-usable device was patient herself and her training status was not provided.The general humapen ergo ii re-usable device model duration of use was not provided but it was started somewhere in 2014.The duration of use of suspect humapen ergo ii re-usable device was unknown.The action taken with suspect humapen ergo ii re-usable device was not provided and its return was not expected.The reporting consumer did not provide the relatedness assessment between the events and the human insulin therapy or suspect humapen ergo ii re-usable device.Update 12nov2021: additional information received on 12nov2021.Entered the device specific safety summary (dsss); updated the medwatch and european and (b)(6) (eu/(b)(6)) device fields for the suspect device.Corresponding fields and narrative updated accordingly.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HUMAPEN ERGO II
Type of Device
FOR TREATMENT PURPOSES
Manufacturer (Section D)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer (Section G)
ELI LILLY AND COMPANY
lilly corporate center
indianapolis IN 46285
Manufacturer Contact
chris davis
lilly corporate center
indianapolis, IN 46285
MDR Report Key12805590
MDR Text Key282735302
Report Number1819470-2021-00150
Device Sequence Number1
Product Code FMF
Combination Product (y/n)N
Reporter Country CodeTU
PMA/PMN Number
K151686
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Consumer,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 11/12/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberMS9557
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/14/2021
Initial Date FDA Received11/12/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age66 YR
Patient SexFemale
-
-